AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05127161 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Broad Implementation of Outpatient Stewardship (BIOS) intervention
Description: The BIOS intervention consists of 3 components: (1) online educational modules covering topics related to appropriate antibiotic prescribing for ARTIs, (2) individualized audit and feedback reports displaying clinicians' rates of antibiotic prescription with peer comparison, (3) facilitation provided by the study team and by health system champions to support effective implementation of the intervention and to encourage clinicians to engage meaningfully in the intervention activities.
Study NCT05573919 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VivAer Stylus
Description: This device will be used to complete its corresponding procedure, which involves reshaping a patient's nasal sidewall tissue through the delivery of radiofrequency heating.
Study NCT05375565 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: weight bearing exercises
Description: * Standing knee raise 10 rep x 2sets~* Standing knee bend 10 rep x 2sets~* Standing hip extension 10 rep x 2sets~* Shallow squats 5 rep x 2 sets After 4 week gradually restricting the use of assistive device when patient become able to walk and stand for 10 mins then add stair climbing and descending with a step height not higher than 7 inch.~The session will be around 45 to 60 minutes on each patient with 2 sessions per week on alternate days to observe the long term effects.
Study NCT05375565 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: non weight bearing exercises
Description: * Seated knee flexion 10 rep x 2sets~* Seated knee extension 10 rep x2sets~* Use of stationary bicycle 10 mins~* Side lying leg lift 10 rep x2sets~* Straight leg raise 10 rep x 2sets The session will be around 45 to 60 minutes on each patient with 2 sessions per week on alternate days to observe the long term effects.
Study NCT05218447 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robotic Gait Training
Description: Subjects will be randomized to one of 4 gait training group. The duration of treatment will span across their inpatient rehabilitation length of stay after providing informed consent to their 9 months post-SCI visit in the outpatient rehabilitation setting.~Subjects will wear an exoskeleton device and receive robotic gait training (RGT) with a physical therapist during a 45-minutes inpatient rehabilitation session. Subjects will complete 24 robotic gait training sessions over different durations during outpatient rehabilitation. Subjects will also complete a transcranial magnetic stimulation (TMS) assessment and questionnaires about walking and function. Subjects will be asked to wear an activity monitor to measure their activity.
Study NCT05218447 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care (UC) Gait Training
Description: Subjects will be randomized to one of 4 gait training group. The duration of treatment will span across their inpatient rehabilitation length of stay after providing informed consent to their 9 months post-SCI visit in the outpatient rehabilitation setting.~Subjects will complete gait training with a physical therapist during a 45-minutes inpatient rehabilitation session. Subjects will also complete a transcranial magnetic stimulation (TMS) assessment and questionnaires about walking and function. Subjects will be asked to wear an activity monitor to measure their activity.
Study NCT05603286 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Home-monitoring
Description: Questionnaires for home-monitoring will be send to the participants 11 weeks after the baseline visit via e-mail using Castor EDC and can be completed using a computer, tablet or smartphone. Home-monitoring can be done together with a parent or guardian, if needed.
Study NCT04714463 — intervention group
Intervention type: PROCEDURE
Intervention: Implant-based breast reconstruction
Description: All types of implant based breast reconstructions
Study NCT06091566 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: UCon-Bar
Description: The participant self-administer electrical stimulation to the dorsal genital nerve (DGN) for either 4 weeks or 12 weeks using UCon with the Bar electrode
Study NCT04714463 — intervention group
Intervention type: PROCEDURE
Intervention: Autologous breast reconstruction
Description: All types of autologous breast reconstructions
Study NCT04714463 — intervention group
Intervention type: PROCEDURE
Intervention: Combined methods
Description: All types of breast reconstructions combining autologous and implant based techniques
Study NCT05476211 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BTL-785F
Description: Radiofrequency
Study NCT05891743 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Patch Test
Description: The Patch Test will include the European baseline series, as well as the epoxy and isocyanate series. Additionally, specific products commonly used in the workplace, such as glues, resins, and paints, will be prepared and included in the testing.
Study NCT05499819 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Canned black beans, drained and rinsed
Description: Canned black beans, drained and rinsed and consumed in a tortilla wrap
Study NCT05499819 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Canned red kidney beans, drained and rinsed
Description: Canned red kidney beans, drained and rinsed, drained and rinsed and consumed in a tortilla wrap
Study NCT05499819 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extra-lean ground beef
Description: Extra-lean ground beef, pan-fried and consumed in a tortilla wrap
Study NCT04872608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole
Description: Letrozole will be given daily on days 1-28.
Study NCT04872608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: Palbociclib will be given daily on days 1-21 and held on days 22-28, as per standard FDA-approved dosing guidelines.
Study NCT04872608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Onapristone ER
Description: Onapristone will be given daily on days 1-28.
Study NCT04752527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: venetoclax combined with decitabine
Description: combination of venetoclax plus decitabine, and sorafenib for patients with high FLT3-ITD allelic ratio. (On day 1 of cycle 1, decitabine 20 mg/m2 will be given intravenously, and will continue for 5 days. Simultaneously the patient will start out with Venetoclax 100mg and progress to 400mg until the 28 day cycle is finished. For patients with high FLT3-ITD allelic ratio, sorafenib was administered at a dose of 400mg orally twice daily, on days 3 through 28.
Study NCT06249776 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Supernova revascularization device
Description: Mechanical Thrombectomy
Study NCT05495230 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Person-centred integrated care intervention
Description: See arm description.
Study NCT05315791 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: different methods for maxillary sinus floor elevation
Description: a: 0\~3mm+ground into pieces; b: 0\~3mm+replace the bone; c: 0\~3mm+turn inward to hold up the membrane; d: 3\~5mm+ground into pieces; e: 3\~5mm+replace the bone; f: 3\~5mm+turn inward to hold up the membrane
Study NCT05750849 — intervention group
Intervention type: PROCEDURE
Intervention: BLOOD COLLECTION FOR P4 DETERMINATION
Description: Serum progesterone levels on the pregnancy test day
Study NCT05495230 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual care
Description: See arm description.
Study NCT05984992 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SRN-001
Description: siRNA therapeutics, Self Assembled Micelle inhibitory RNA platform utilized
Study NCT05984992 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% Sodium Chloride(Normal saline)
Study NCT06311513 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Concentrated Bone Marrow Aspirate Injection
Description: Intraoperatively, bone marrow will be harvested from the iliac crest with a commercial kit, it will then be prepared via centrifugation and an injection of the resulting concentrated product (cBMA) will be administered in the operative knee. cBMA is an autologous biologic product.
Study NCT06311513 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham Incision
Description: A 2 mm sham incision will be made in the anatomical site where bone marrow would be harvested.
Study NCT06311513 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Revision Anterior Cruciate Ligament Reconstruction
Description: This is the standard-of-care surgical procedure.
Study NCT06311513 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Revision Anterior Cruciate Ligament Reconstruction
Description: This is the standard-of-care surgical procedure.
Study NCT05902858 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional intubation with hyperangulated videolaryngoscope
Description: After the induction of general anesthesia, the patient will undergo conventional intubation with hyperangulated videolaryngoscope
Study NCT05902858 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intubation with ProVu TM video stylet combined with hyperangulated videolaryngoscope
Description: After the induction of general anesthesia, the patient will undergo intubation with ProVu TM video stylet combined with hyperangulated videolaryngoscope
Study NCT05902858 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intubation with ProVu TM video stylet combined with standard Macintosh laryngoscope
Description: After the induction of general anesthesia, the patient will undergo intubation with ProVu TM video stylet combined with standard Macintosh laryngoscope
Study NCT06305858 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prosthetic Surgical Procedure
Description: The population consists of 48 patients divided into two groups:~24 patients Group A experimental group: partial denture surgical procedure~24 patients Group B control group: total denture surgical procedure with patellar resurfacing
Study NCT06305858 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Prosthetic Surgical Procedure
Description: The population consists of 48 patients divided into two groups:~24 patients Group A experimental group: partial denture surgical procedure~24 patients Group B control group: total denture surgical procedure with patellar resurfacing
Study NCT05807750 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post-discharge income supplement
Description: $300 income supplement
Study NCT05807750 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced care planning
Description: Enhanced care planning provided by a nurse care manager
Study NCT05807750 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhanced care planning
Description: Enhanced care planning provided by a nurse care manager
Study NCT05026658 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Visibly Digital Acuity Product
Description: The order of testing (two VDAP home environments and ETDRS) will be randomly assigned for each subject as one of four sequences:~1. V1, E, V2~2. E, V1, V2~3. V2, E, V1~4. E, V2, V1~Where E denotes the ETDRS assessment, V1 denotes the VDAP assessment in home environment 1, and V2 denotes the VDAP assessment in home environment 2.~The randomization will be blocked in groups of 4 subjects to ensure balance for the VA testing sequences.
Study NCT05943756 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Signature Strengths
Description: The treatment group will complete 6 web-based sessions of Signature Strengths(1 sessions per week for 6 weeks), designed to teach lessons focused on the Aware-Explore-Apply interventional framework. Sessions are approximately 60 minutes long.
Study NCT05943756 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TBI Education Course
Description: The control group will complete 6 web-based sessions of a TBI Education Course(1 sessions per week for 6 weeks), designed to teach lessons based on the TBI Model Systems Knowledge Translation Center's fact sheets. Sessions are approximately 60 minutes long.
Study NCT06286930 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: anodal trans cranial direct current stimulation (tDCS)
Description: 1 20-minute anodal tDCS stimulation
Study NCT06286930 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: cathodal trans cranial direct current stimulation (tDCS)
Description: 1 20-minute cathodal tDCS stimulation
Study NCT05275829 — intervention group
Intervention type: OTHER
Intervention: Tele simulation
Description: Interactive tele simulation sessions utilising web-based video-conferencing technology (WebEx platform).
Study NCT06511505 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TEMPUS AI-enabled ECG-based Screening Tool
Description: The AI-enabled ECG-based screening tool, Tempus Next software, analyzes 12-lead ECG recordings to identify patients at increased risk for undiagnosed cardiovascular diseases, specifically atrial fibrillation (AF) and structural heart disease (SHD). Clinicians in the intervention group will receive a risk assessment for AF and SHD each time they order an ECG for their patients.
Study NCT05061225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity counselling
Description: Educational content on several topics regarding physical activity and its implementation in daily living
Study NCT06312007 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Semi seated position
Description: The patient is positioned 45-90 degrees
Study NCT06312007 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: side lying position
Description: Side lying position
Study NCT06203678 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesio taping
Description: therapeutic tape application
Study NCT06203678 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Exercise
Description: Cervical stretching and strengthening exercises home program
Study NCT06203678 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Cervical stretching and strengthening exercises home program
Study NCT06203678 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Exercise
Description: Cervical stretching and strengthening exercises home program
Study NCT06203678 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham taping
Description: patch tape application
Study NCT05359627 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Polymyxin B
Description: Polymyxin B acts against gram-negative bacteria (GNB) only, via three known mechanisms of action: First, polymyxin B can electrostatically interact with the outer membranes of GNB to compete against and displace calcium and magnesium divalent cations from membrane lipids, thereby disrupting lipopolysaccharide (LPS) molecules on the outer membrane and triggering their release. This leads to changes in the permeability of the bacterial membrane and subsequently causes cell content leakage, cell lysis, and death. Second, polymyxin B can act as a surfactant, as it is amphipathic and contains both lipophilic and lipophobic groups; this allows it to penetrate cell membranes, interact with the phospholipids within, and rapidly disrupt membranes to kill bacteria. Third, polymyxin B can bind to the lipid A portion of bacterial endotoxin or LPS molecules, thus neutralizing their toxicity.
Study NCT05507164 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Temporomasseteric Nerve Block
Description: The TMNB injection is a local anesthetic injection technique that targets the anterior deep temporal and masseteric branches of the mandibular division of the Trigeminal Nerve. The surface landmark for the twin block injection site is located by palpating for the depression created by the greater wing of the sphenoid bone at the superior border of the zygomatic process and approximately 1 cm posterior to the posterior border of the frontal process of the zygomatic bone. This site is first disinfected with alcohol wipes prior to inserting a 27- or 25-gauge long dental needle (32 mm). Angled 35-45° away from the calvarium (skull) and perpendicular to the zygomatic arch (along the coronal plane), the needle is advanced to its length before injecting 1.8 mL of 2% lidocaine with 1:100,000 epinephrine.
Study NCT06238700 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: pregnenolone
Description: Pregnenolone is an endogenous steroid available in the US and elsewhere as an orally administered over-the-counter supplement.
Study NCT06238700 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo pills are identical-appearing capsules containing cellulose
Study NCT04357093 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Grape seed extract mouthwash
Description: Mouthwash 15% grape seed extract
Study NCT04357093 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sodium fluoride mouthwash
Description: Sodium fluoride mouthwash
Study NCT06223139 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Handgrip strength
Description: Handgrip strength will be measured by 3 efforts.
Study NCT06113614 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Physiotherapy
Description: All participants will be treated with the standardized physiotherapy protocol suggested by Ratajczak et al. 2019. To receive physiotherapy treatment, participants will need to attend a 30-minute session, twice a week, for 12 weeks.
Study NCT06015191 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Remote Cardiac Rehabilitation
Description: Participants will engage in a ramp-up period (weeks 0-2) where participants will attend 1-on-1 live, remote in-home exercise sessions (20-35 min./session, 3-days/wk.) delivered by a health coach via telehealth video conferencing. Participants will be provided a tablet computer and a small set of equipment. Following the ramp-up period, participants will be asked to attend live, in-home, group-based exercise sessions (weeks 3-12, 3-5 participants/group, 45-min, 3-days/wk. minimum). Sessions will be offered 4-days/wk. in the afternoons and early evenings allowing participants to select the most convenient 3 days per week to attend. Sessions will include a variety of dynamic aerobic and anaerobic (resistance) exercises with a target heart rate corresponding to 60-75% of VO2peak. In the group-based exercise sessions, participants will be able to see, hear, and verbally interact with the health coach and the other participants, allowing for supervision and encouraging social support.
Study NCT06015191 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Control
Description: Participants will receive a handout describing physical activities appropriate for their congenital heart disease diagnosis and providing recommendations consistent with the physical activity recommendations for children and adolescents.
Study NCT06397534 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education
Description: In the experimental group, students will be administered the Introduction Characteristics Form, Stoma Care Knowledge Assessment Form (pre-test), and the General Self-Efficacy Scale (pre-test). Subsequently, digital materials (such as stoma care presentation materials and stoma care demonstration videos) will be prepared by the researchers. The video content will be uploaded to the 'Edpuzzle' program, which is accessible via internet connection or downloadable to devices. The video content in the 'Edpuzzle' program will consist of stoma care procedural steps. Following this, students will apply the stoma care skill in the skills laboratory under the supervision of instructors. To reinforce the implementation in the experimental group, online activities such as word clouds and quizzes will be sent. After the implementation and 4 weeks later, the 'Stoma Care Knowledge Assessment Form (post-test)' and the 'General Self-Efficacy Scale (post-test)' will be administered online.
Study NCT06667167 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Induction Carboplatin
Description: Induction phase of carboplatin+etoposide+pembrolizumab followed by maintenance of Pembrolizumab+sacituzumab govitecan
Study NCT06113614 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Description: All participants will be treated with the standardized physiotherapy protocol suggested by Ratajczak et al. 2019. To receive physiotherapy treatment, participants will need to attend a 30-minute session, twice a week, for 12 weeks.
Study NCT06113614 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Photobiomodulation
Description: The PBM will be applied with LED devices in the form of a shoulder brace. The applications will occur every day starting 24 hours after the surgical procedure. The shoulder brace from the brand Cosmedical (Mauá, SP, Brazil) contains 70 red LEDs and 70 infrared LEDs. The area corresponding to the fixation plate will not be irradiated (no LEDs will be placed). PBM will be applied every day for 10 minutes using a device containing 318 light-emitting diodes (LEDs), including 159 LEDs at 660 nm (28.5 mW; 12 J/cm2 to 17 J) and 159 LEDs at 850 nm (23 mW; 10 J/cm2 to 14 J).
Study NCT05039203 — intervention group
Intervention type: DEVICE
Intervention: Indwelling urinary catheter
Description: Removal of indwelling urinary catheter
Study NCT06678880 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Phase Advanced Intervention (PAI)
Description: Phase-advanced restricted sleep (i.e., sleep 9pm-1am only) for 1 night, followed by morning bright white light for 30 min/day for 2 weeks.
Study NCT06678880 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Phase Delay Intervention (PDI)
Description: Phase-delayed restricted sleep (i.e., sleep 3am to 7am only) for 1 night, followed by evening bright white light for 30 min/day for 2 weeks.